I really can't believe that Sumner (who is a decent writer) can pump Sotrovimab so hard but then cast a doubting eye on Leron. The commonplace designation of CD10 and CD12 as "failed trials" is like a scarlet letter that cannot be ignored -- it begins to be the only thing visible about the company. If Sumner actually looked at the topline results for CD12 (let alone the cancer prelim results), I think he'd be amazed.

But the arrogance is hard to bear. Who does the guy think he is?